EU Projects. SOP-ICE Project
SOP-ICE Project: Equipment for the Specialist “Oral” Vaccine Laboratory
The Institute of Biotechnology and Antibiotics as a coordinator of the IBA BIOTON Advanced Technology Centre (Centrum Zaawansowanych Technologii) together with the Koprowski Foundation (Fundacja im. Koprowskich) runs the project known as “Equipment for the Specialist ‘Oral’ Vaccine Laboratory”. The project is carried out under the Sectoral Operational Program “Improvement of the Competitiveness of Enterprises” (SOP-ICE). Funding for the project derives from the SOP-ICE as follows: the European Community funds from the European Fund for Regional Development in the amount of PLN 6 604 657.13 and domestic funds from the state budget in the amount of PLN 2 201 552.38. These funds are provided under agreement no. WKP_1/1.4.3/2/2005/87/207/505/2006/U with the Minister of Science and Higher Education.
The purpose of the project is to create a laboratory in the IBA with full capacity to conduct research on the development of new recombined antigens against major infections, in particular against the avian influenza, using eukaryotic and prokaryotic organisms as well as evaluate the potential of the alimentary tract as the route of immunization which would lead to the development and manufacturing of an “oral” vaccine. The specialist equipment to be purchased will allow for the execution of the project of the development of a new vaccine with an original and innovative route of administration. The final outcome is to include the creation of the laboratory with the quality system required for vaccines and medications where it will be possible to develop recombined organisms with properties suitable for industrial use. The next stage will be the creation of the intended product by the development and execution of the concept of predesigned genetic structure, transformation of host organism and isolation, transformation and purification of a product. The laboratory equipment will enable the performance of comprehensive biochemical analyses, which is necessary for the evaluation of biosynthetic preparation usefulness, according to requirements of the medicinal product registration procedure.
The Project was completed in June 2008.
